Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Cellular Taxonomy of the Mouse Striatum as Revealed by Single-Cell RNA-Seq
2016 Nobel
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Heparin-Protein Interactions
2002 Standout
Platelet Count Monitoring and Laboratory Testing for Heparin-Induced Thrombocytopenia
2002
Heparininduzierte Thrombozytopenie als Komplikation der postoperativen Thromboseprophylaxe mit UFH/NMH-Heparinen nach Hüft- und Knieendoprothetik
2002
Affinity purification of heparin‐dependent antibodies to platelet factor 4 developed in heparin‐induced thrombocytopenia: biological characteristics and effects on platelet activation
2000
Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia
2006
Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?
2005
Perioperative Parenteral Tranexamic Acid in Liver Tumor Resection
2006
Single-cell-resolution transcriptome map of human, chimpanzee, bonobo, and macaque brains
2020 StandoutNobel
High incidence of anti‐heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery
1998
Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?
2000
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Heparin‐induced thrombocytopenia: pathogenesis and management
2003
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Antithrombotic Therapy for VTE Disease
2016 Standout
Recurrence of venous thromboembolism in patients with familial thrombophilia
1997
PATHOBIOLOGY OF PULMONARY HYPERTENSION
2001
Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes
2007
Heparin-Induced Thrombocytopenia
1998
Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study
2010 StandoutNobel
Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome
2003
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
Prethrombotic Disorders in Children With Arterial Ischemic Stroke and Sinovenous Thrombosis
1999
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Heyde syndrome: a common diagnosis in older patients with severe aortic stenosis
2008
A possible association between aprotinin and improved survival after radical surgery for mesothelioma
2009
Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome
2004
Surgical restoration of portal flow corrects procoagulant and anticoagulant deficiencies associated with extrahepatic portal vien thrombosis
2003
Vascular disorders of the liver # †
2008 Standout
The Efficacy of Antifibrinolytics in the Reduction of Blood Loss During Complex Adult Reconstructive Spine Surgery
2001
Antithrombotic Therapy for VTE Disease
2012 Standout
Chorioamnionitis as a Risk Factor for Cerebral Palsy
2000 Standout
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Neonatal cytokines and coagulation factors in children with cerebral palsy
1998
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
Cerebral Sinovenous Thrombosis in Children
2001 Standout
Serologic evidence of heparin sensitization in cancer patients receiving heparin flushes of venous access devices
1999
Frequency of Heparin‐Induced Thrombocytopenia in Critical Care Patients
2003
Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassays
2008
Inherited prothrombotic states and ischaemic stroke in childhood
1998
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Prevention of Venous Thromboembolism
2004 Standout
Testing for Heparin-Induced Thrombocytopenia Antibodies
2006
High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension
2003
Hypoxic gene expression and metastasis
2004
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
2010
Portal vein thrombosis in adults: pathophysiology, pathogenesis and management
2000
Prevention of Venous Thromboembolism
2008 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1999
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Acquired von Willebrand Syndrome in Aortic Stenosis
2003
Tranexamic Acid Reduces Perioperative Blood Loss in Adult Patients Having Spinal Fusion Surgery
2008
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Acquired platelet dysfunction may be an aetiologic factor in Heyde's syndrome – normalization of bleeding time after aortic valve replacement
2002
Heparin-induced Thrombocytopenia, a Prothrombotic Disease
2007
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia
1997
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Chronic thromboembolic pulmonary hypertension
2014
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
Etiology of stroke in children
2000
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
Factor V Leiden: A Clinical Review
2001
Chemokine RANTES in Severe Pulmonary Arterial Hypertension
2002
CX 3 C Chemokine Fractalkine in Pulmonary Arterial Hypertension
2002
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Distúrbios trombofílicos em crianças e adolescentes com trombose da veia porta
2003
Life with Oxygen
2007 StandoutScienceNobel
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies
2000
Maturation of the hemostatic system during childhood
1992 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4–heparin antibodies to platelets and the resultant platelet activation
2000
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Heparin-induced Thrombocytopenia: Towards Consensus
1998
Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
State-of-the-Art Review : Heparin-induced Thrombocytopenia and Thrombosis Syndrome
1998
FcγRIIA H/R131 Polymorphism, Subclass-Specific IgG Anti-Heparin/Platelet Factor 4 Antibodies and Clinical Course in Patients With Heparin-Induced Thrombocytopenia and Thrombosis
1997
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance
2000
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
The Risk of Recurrent Venous Thromboembolism in Carriers and Non-carriers of the G1691A Allele in the Coagulation Factor V Gene and the G20210A Allele in the Prothrombin Gene
1999
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
2013
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
First Workshop for Detection of Heparin-induced Antibodies: Validation of the Heparin-induced Platelet-activation Test (HIPA) in Comparison with a PF4/Heparin ELISA
1999
Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia
1996
Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody
2002
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
Bleeding and Thrombosis in Patients With Continuous-Flow Ventricular Assist Devices
2012
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Predictive Value of D-Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital Thrombophilia
2003
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
Antifibrinolytic Therapy and Perioperative Blood Loss in Cancer Patients Undergoing Major Orthopedic Surgery
2003
Antibodies to Platelet Factor 4–Heparin After Cardiopulmonary Bypass in Patients Anticoagulated With Unfractionated Heparin or a Low-Molecular-Weight Heparin
1999
Works of Martine Wolf being referenced
Aprotinin Reduces Blood Loss in Patients Undergoing Elective Liver Resection
1997
Pathogenicity of IgA and/or IgM antibodies to heparin–PF4 complexes in patients with heparin‐induced thrombocytopenia
1996
Reduction of Blood Loss and Transfusion Requirement by Aprotinin in Posterior Lumbar Spine Fusion
1999
Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin
1996
Temporary protein C deficiency associated with cerebral arterial thrombosis in childhood
1988
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract
2001
Aprotinin Reduces Blood Loss in Patients Undergoing Elective Liver Resection
1997
Protein C, protein S and antithrombin III in children with portal vein obstruction
1997
Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension
2000
Reduction of Blood Loss and Transfusion Requirement by Aprotinin in Posterior Lumbar Spine Fusion
1999
Familial type I protein S deficiency associated with severe venous thrombosis--a study of five cases.
1988
Clinical Features in 36 Patients Homozygous for the ARG 506 → GLN Factor V Mutation
1997